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Although infections with NonTuberculous Mycobacteria have become less common in
AIDS  patients, they are important opportunistic infections after surgical procedures, likely
because they are ubiquitous and not efﬁciently killed by many commonly used disinfectants.
In  Venezuela there have recently been many non-tuberculous mycobacteria soft tissue infec-
tions after minor surgical procedures, some apparently related to the use of a commercial
disinfectant based on a Quaternary Ammonium Compound. We  studied the activity of this
and  other quaternary ammonium compounds on different non-tuberculous mycobacteria
by  transforming the mycobacteria with a dnaA-gfp fusion and then monitoring ﬂuorescence
to  gauge the capacity of different quaternary ammonium compounds to inhibit bacterial
growth. The minimum inhibitory concentration varied for the different quaternary ammo-
nium compounds, but M. chelonae and M. abscessus were consistently more resistant than
M.  smegmatis, and M. terrae more resistant than M. bovis BCG.NTM) ©  2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
s arti
ria are generally regarded as opportunistic agents requiringesistance
ost-surgical infections
an  open acces
ntroduction
he advent of highly effective anti-retroviral therapy1,2 has
ed to a decrease in NonTuberculous Mycobacterial (NTM)
nfections in patients with the HIV/AIDS syndrome,3 but they
re relatively common in patients with cystic ﬁbrosis, and
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have recently become notorious as contaminant infections
after major and minor surgery, particularly NTM of the M.
abscessus complex.4,5 Although these low virulence bacte-direct inoculation into a wound site, treating them is often
difﬁcult and requires prolonged multi-drug therapy, as they
are intrinsically resistant to most antibiotics,6,7 including
lsevier Editora Ltda. This is an open access article under the CC
.
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Fig. 1 – Plasmid pFPV27 (pdnaA-gfp), the dnaA promoter152  b r a z i l i a n j o u r n a l o f m
several of those used to treat M. tuberculosis.8 Their fre-
quency as post-procedural contaminants is likely related to
several factors: they are fairly ubiquitous in the environ-
ment, especially in soil9 and water10,11; they can form bioﬁlms
in tap water systems10–12; they are resistant to the antibi-
otics generally used for surgical prophylaxis8–13; and they
appear to be able to survive exposure to many  commonly
used disinfectants.14,15 The recent popularity of conventional
and non-conventional cosmetic procedures in Venezuela,
often performed by diverse practitioners in less than optimal
settings, has engendered a minor epidemic of NTM infec-
tions of the skin and soft tissues. Many  of these cases were
apparently caused by non-sterile techniques or the use of con-
taminated materials during surgery, liposuction, foreign body
implantation, mesotherapy, acupuncture, or soft tissue aug-
mentation, but incomplete disinfection of the skin prior to
these procedures has also been implicated.16 The label of the
disinfectant product most commonly used in medical settings
in Venezuela stated that it would sterilize surgical instru-
ments and anything else after only a 20-min exposure, and
that it was tuberculocidal. These claims, based upon stud-
ies with M.  smegmatis,  appeared questionable, because the
active ingredient is a QAC, a class of disinfectants regarded
as having only mycobacteriostatic activity. As the dispute
over the effectiveness of the product has provoked several
civil suits, it seemed necessary to evaluate the activity of
this product and other QACs against several NTM, includ-
ing some clinical isolates.17 A number of fairly complicated
methods have been proposed to evaluate the ability of dis-
infectants to reduce or eliminate bacteria from surfaces or
surgical equipment.18 Our purpose, however, was to evaluate
the activity of several QACs over a range of concentrations
against different NTM known to represent a range of innate
resistance.7,19 To accomplish this in a tractable format, we
labeled four NTM and M.  bovis BCG with green ﬂuorescent
protein (GFP) and tested the ability of different concen-
trations of the compounds to reduce bacterial growth, as
measured by ﬂuorescence. A similar assay was described
previously.20
Materials  and  methods
Strains  and  plasmids
M.  smegmatis mc2155 is a strain commonly used in the lab-
oratory (LGM, IVIC), M.  chelonae (LT 1529) and M.  abscessus
subspecies abscessus (LT 949) were clinical strains isolated
in Caracas (Lab. TB, Inst. Biomedicina), M. bovis BCG (ATCC
35734) and M.  terrae (ATCC 15755) was obtained from the Amer-
ican Type Culture Collection. The strains were grown at 37 ◦C
in Middlebrook 7H9 liquid media supplemented with 10%
OAD (oleic acid 0.05%, bovine serum albumin 5%, dextrose
2%), 0.2% glycerol and 0.05% Tween 80 (7H9-OAD-Tw), or on
Petri dishes containing Middlebrook 7H10 supplemented with
10% OAD and 0.2% glycerol. The species of the strains used
were conﬁrmed with the PRA method.21 Plasmids pYUB412
and pFPV2722,23 were the kind gifts of Dr. Lalita Ramakr-
ishnan, and Drs. Martin Pavelka and William R. Jacobs Jr.,
respectively.region from M.  tuberculosis.
Cloning  of  the  dnaA-gfp  fusion
Reagents for DNA manipulations were obtained from commer-
cial sources and used according to routine protocols. For the
construction of plasmid pdnaA-gfp,  the dnaA promoter region
from M.  tuberculosis (582 bp) was ampliﬁed from a cosmid24
containing the rpmH–dnaA region, using primers GLRA3 (5′
cta tgt ctg gca aca t) and GLRA4 (5′ tat ctc cct ggt tct cgt ta),
and ligated upstream of gfp into the BamHI and EcoRV sites
of pFPV27 (Fig. 1). The chromosomal integrating version of
the dnaA-gfp fusion, on plasmid pintdnaA-gfp, was obtained
by cloning a BamHI–BclI fragment from pdnaA-gfp into the BclI
site of pYUB412.22 Plasmids pdnaA-gfp and pintdnaA-gfp were
electroporated into the mycobacterial strains and plated onto
kanamycin (pdnaA-gfp)  or hygromycin (pintdnaA-gfp) selective
media. GFP-expressing mycobacteria were visualized for ﬂuo-
rescence using a Nikon Eclipse 600 ﬂuorescence microscope.
Monitoring  bacterial  growth  by  ﬂuorescence
A colony of mycobacteria from solid media was inocu-
lated into 5 mL  of 7H9 OAD-Tw, with kanamycin 50 g/mL
when the strains contained plasmid pdnaA-gfp,  or hygromycin
100 g/mL for strains with integrating plasmid pintdnaA-gfp, in
a 50 mL  conical tube, and grown with agitation at 37 ◦C until
reaching exponential phase, then transferred to 50 mL  of the
same media and grown in 500 mL  ﬂasks. For the initial studies
comparing ﬂuorescence vs. growth, samples were taken peri-
odically to measure the optical density and ﬂuorescence every
3 h for M.  smegmatis,  every 6 h for M. abscessus and every 24 h
for M.  chelonae, M.  bovis BCG and M.  terrae. Optical density at
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00 nm (OD600) was measured in a 96 well spectrophotometer
Molecular Devices Spectramax 340), and ﬂuorescence (485 nm
xcitation and 535 nm emission) was measured in a 96 well
late ﬂuorimeter (Molecular Devices SpectraMax, GeminisXS).
liquots were also diluted and plated on 7H10-OAD plates to
etermine colony-forming units (CFU).
isinfectants
he disinfectants evaluated were: cetyltrimethyl ammonium
romide (CTAB), dodecyl trimethyl ammonium bromide
DTAB), cetylpyridinium chloride (HPC) and dimethyl benzyl
auryl ammonium bromide (DBLAB – marketed under a com-
ercial product name http://www.pharmcast.com/Patents/
r2002/August2002/082702/6441045 Disinfectant082702.htm).
he disinfectants were prepared by dissolving CTAB, HPC, or
TAB in 50 mL  volumes of 7H9-OAD-Tw to obtain 4% solutions
f each. DBLAB, as the commercial product, was diluted
ith 7H9-OAD-Tw to a concentration of 4%. All disinfectants
olutions were kept at 4 ◦C until used.
tudies  with  disinfectants  and  antibiotics
he different bacteria were grown in 50 mL  conical tubes, as
escribed above, until reaching an OD600 of approximately 1.0.
ive millilitres of each were then transferred to a new 50 mL
onical tube, 10 sterile glass beads were added, and the tube
as vortexed for 20 s to reduce clumping. The tubes were
eft to stand at room temperature for 15 min  then 100 L was
dded to 9.9 mL  of 7H9OAD-Tw. One millilitre of this suspen-
ion was then added to 9 mL of the same media, which was
hen mixed and used in the 96 well plate assay.
ssay  of  disinfectant  activity  using  ﬂuorescent
ycobacteria
he assay was performed using black 96 well plates, one dis-
nfectant per plate. 200 L of the highest concentration of
he disinfectant to be tested was placed into the wells in
he ﬁrst column, and 100 L 7H9 OAD-Tw added to the wells
n the other columns. 100 L from the wells with the high-
st disinfectant concentration were diluted into the 100 L
H9 OAD-Tw in the next column, and the dilution process
erially repeated to obtain ﬁnal concentrations of 4%, 2%,
%, 0.5%, 0.25%, 0.125%, 0.06% until 0.00003%. 100 L of the
ycobacterial suspension were then added into each well.
ositive controls without disinfectants and negative controls
ith media alone were included on each plate. The plates were
ncubated with agitation at 37 ◦C and the ﬂuorescence read
eriodically over 4 days in a ﬂuorimeter.
IC  determination  with  Alamar  Blue
he Alamar Blue tests25–27 were performed in transparent 96
ell plates with inocula, controls and detergent concentra-
ions prepared as described above. Detergent concentrations
ere tested in duplicate. The plates were incubated at
7 ◦C with agitation for different times depending upon the
ycobacterial species being tested (M.  smegmatis 3–4 days
nd M.  chelonae and M. abscessus 5–6 days), and then 30 L ofo l o g y 4 8 (2 0 1 7) 151–158 153
Alamar Blue was added to the positive control wells. If, after a
further 24 h of incubation, the initial blue in the positive con-
trols had turned a fuchsia color, Alamar Blue was added to
the other wells and incubated for another 24 h. In reading the
results, the positive and negative controls were used as refer-
ences. The MIC corresponded to the lowest concentration in
which the intensity of the color change was equal to or less
than the negative controls.
MIC  determination  by  plate  dilution
For the plate dilution method,28 60 mm Petri dishes were
prepared using 7H10-OAD media containing serial twofold
decreasing concentrations of the disinfectants from 0.50%
through 0.0005%. Solidiﬁed plates were spread in duplicate
with 100 L of an inoculum containing ∼104 bacteria per mL
and incubated at 37 ◦C for 3 days for M. smegmatis,  5 days for
M.  abscessus and 8 days for M.  chelonae. Control plates had no
disinfectant.
Evaluation  of  antibiotic  activity  against  M.  abscessus
M.  abscessus was grown and the inocula prepared and
diluted, as described above, to contain 104–5 bacteria per
mL.  The antibiotics clarithromycin, rifampicin, meﬂoxine and
amikacin were purchased from Sigma–Aldrich. Moxiﬂoxacin
was obtained from the NIH AIDS repository program. The ﬁve
drugs were tested in triplicate in each 96 well plate assay,
at concentrations of 128, 64, 32, 16, 8, 4, 2, 1 and 0.5 g/mL,
obtained by serial dilutions as described above. 100 L of the
bacterial suspension was added to the appropriate wells, the
plates were covered and sealed with tape to prevent evapora-
tion, and then incubated at 37 ◦C. with agitation. Fluorescence
was measured daily for 3 days, and each assay was performed
at least 3 times.
Results
Construction  of  GFP  labeled  mycobacterial  strains
In this work we employed a GFP-based expression system
to assess the growth inhibitory properties of distinct QACs
disinfectants and antibiotics against different mycobacterial
species. The gfp gene was fused to M.  tuberculosis dnaA pro-
moter, as expression of this promoter is induced during the
growth cycle of mycobacteria, and thus expression of gfp and
its innate ﬂuorescence should reﬂect bacterial growth. The
multicopy (pdnaA-gfp) and integrating single copy (pintdnaA-
gfp) plasmid versions were electroporated separately into M.
smegmatis. Transformants with either plasmid were seen to
ﬂuoresce under a ﬂuorescent microscope, but the ﬂuorescence
was much stronger in the strains carrying the multicopy ver-
sion of the fusion (data not shown). Preliminary studies with
strains carrying the integrated version of the pintdnaA-gfp
fusion indicated that to obtain an adequate signal to noise
ratio it was necessary to begin with of least a million bacteria
per well, but at this density the cultures were rapidly satu-
rated and the effects of the drugs and disinfectants on growth
inhibition were difﬁcult to detect (Fig. 2A and B).
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Fig. 2 – (A) Comparison of the ﬂuorescence of cultures (RFU-Relative Fluorescent Units) with their Optical Density (OD600) for
M. smegmatis strains with no gfp fusion (WT) or M.  smegmatis with either the multicopy (pdnaA-gfp) or single copy
(pintdnaA-gfp) integrated version of the GFP fusion. (B) Comparison of the ﬂuorescence (RFU) with colony counts (CFU –
Colony Forming Units) of the same strains shown in (A). All results are from representative experiments that were  repeated
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Fig. 3 – Activity of DBLAB against M.  abscessus carrying the
pdnaA-gfp fusion on a multi-copy plasmid was determined
in a 96 well format. Bacterial growth was measured daily
over 4 days with a ﬂuorimeter and expressed as Relative
Fluorescent Units (RFU) shown on log scale. The
experiment was performed in triplicate.at least three times.
In contrast, strains carrying the multicopy plasmid version
of the dnaA-gfp fusion provided sufﬁcient ﬂuorescence to mon-
itor bacterial growth starting with 104–5 bacteria per well, and
were used for all subsequent studies. For these strains the
increase in ﬂuorescence produced by bacterial growth in 96
well plates correlated closely with determinations of bacterial
growth both by optical density (OD600) (Fig. 2A), and by colony
counts of serial dilutions plated on solid media in Petri dishes
(Fig. 2B).
Use  of  GFP  ﬂuorescence  to  determine  relative  activity  of
four QACs  against  M.  smegmatis,  M.  chelonae,  M.
abscessus.  M.  terrae  and  M.  bovis  BCG
Strains of M.  smegmatis,  M. chelonae, M. abscessus, M. terrae and
M.  bovis BCG were transformed with the pdnaA-gfp and inoc-
ulated into serially decreasing concentrations of CTAB, DTAB,
HPC and DBLAB. Fluorescence was monitored daily, as shown
for M.  abscessus upon exposure to disinfectant DBLAB (Fig. 3).
After four days of growth, DTAB appeared to be the most
active compound, suppressing growth of all ﬁve strains at con-
centrations as low as 0.062%. With HPC and CTAB, growth
was suppressed at concentrations as low as 0.25%. In CTAB,
there was essentially no growth at concentrations of 0.25% or
higher, slight growth of M. chelonae and M. abscessus at concen-
trations from 0.125% through 0.016%, and abundant growth
at lower concentrations. A similar pattern was seen for M.
abscessus in HPC. M.  smegmatis was markedly more  suscep-
tible to CTAB and DTAB than the other two strains, while M.
abscessus was more  resistant to DBLAB and HPC than both M.
chelonae and M. smegmatis. M. bovis BCG was even more  sen-
sitive than M.  smegmatis,  and M. terrae slightly more  resistant
(Fig. 4).Comparison  of  the  ﬂuorescent  method  with  the  Alamar
Blue and  plate  dilution  assays
In parallel studies, the capacity of the QACs disinfectants
to inhibit the mycobacterial growth of M. smegmatis,  M.  che-
lonae and M.  abscessus was measured in a microwell Alamar
Blue assay and also by the plate dilution method. The MICs
obtained with the three methods are compared in Fig. 5. The
plate assay showed the least variation of inhibitory concen-
trations with the three strains and tended to produce lower
MICs. M.  abscessus showed the least differences with the three
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Fig. 4 – Activity of four QACs disinfectants tested in decreasing concentrations against M.  smegmatis, M.  abscessus,  M.
chelonae, M.  terrae and M.  bovis BCG, all carrying the dnaA-gfp fusion on a multi-copy plasmid. The assays were  performed
in a 96 well format and bacterial growth after 4 days of incubation was measured as Relative Fluorescent Units (RFU) and
shown on a log scale. The QACs tested were DBLAB, HPC, CTAB and DTAB. All results are averaged from experiments
performed at least three times.
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oethods and M.  chelonae the greatest discrepancies. M. che-
onae and M. abscessus were generally more  resistant than M.
megmatis. DBLAB, the ingredient of the commercial product
ad much higher MICs than the other three QAC disinfectants
ested. The results of the Alamar Blue and ﬂuorescent assays
iffered from those of the plate assay, with a roughly equiv-
lent degree of variance. In most cases the differences in the
ICs amongst the different methods were within a range of
–3-fold.
se  of  GFP  ﬂuorescence  to  determine  relative  activity  of
ntibiotics  against  M.  abscessus
o evaluate the utility of the ﬂuorescent assay for deter-
ining the sensibility of mycobacteria to therapeutic agents,
e tested various antibiotics against gfp labeled M. absces-
us in an assay similar to that used for the QACs
bove (Fig. 6). Of the antibiotics tested against M.  absces-
us, clarithromycin clearly had the best activity, followed
y moxiﬂoxacin > amikacin > rifampin > meﬂoquine, in that
rder.Discussion
We  have evaluated the activity of four QACs against differ-
ent species of NTM and ﬁve antibiotics against M. abscessus
using GFP labeled bacteria, and have shown that mea-
surement of GFP ﬂuorescence, when expressed from the
growth-dependant dnaA promoter, is a convenient way to
determine the sensitivity of mycobacteria to both QAC dis-
infectants and antibiotics. Further, we have conﬁrmed that M.
abscessus and M. chelonae are signiﬁcantly more  resistant to
QACs than M.  smegmatis.29,30 Although the activities of differ-
ent QACs vary somewhat depending upon the mycobacterial
species, DBLAB was the least effective of those tested. How-
ever, using M.  smegmatis to assess the activity of disinfectants
against all NTM could lead to disastrous over-estimations of
the capacity of QACs and other disinfectants to eliminate the
species that are most commonly associated with infections,
such as M.  abscessus or M. chelonae.In other studies, not shown, we  conﬁrmed that M. terrae,
proposed as a proxy for the susceptibility of M.  tuberculosis,31 is
more resistant to the QACs than M. bovis BCG. Therefore, while
BCG is a closer model for determining the resistance proﬁle of
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Fig. 6 – Activity of ﬁve antibiotics against GFP labeled M.
abscessus, determined as ﬂuorescence after 72 h of
incubation in media containing the drugs at the
concentrations indicated. The experiment was performed
in triplicate.
M.  tuberculosis, testing with M. terrae should provide of mar-
gin of safety. In studies similar to those in Fig. 6, not shown,
we also found that ﬂuorescent M.  bovis BCG can be employed
to assess the activity of antibiotics against M. tuberculosis. Thet were  repeated at least three times.
differences in the relative sensitivity of different mycobacteria
to disinfectants and other anti-bacterial agents is likely deter-
mined by the composition of the complex, lipid rich, relatively
impermeable cell envelope, but the possible involvement of
efﬂux pumps32 or differences in porin-like structures33 cannot
be excluded. The GFP method produces results that, although
often slightly different from the MICs obtained with the plate
dilution method, are similar to those obtained with the Ala-
mar Blue 96 well plate method, which also uses liquid media. It
is less labor intensive than the other methods, but the format
requires a ﬂuorimeter that can read multi-well plates. The ﬂu-
orescent mycobacteria can provide a facile and rapid system
for evaluating the growth inhibiting effects of detergents and
antibiotics and could be used for high throughput screening of
new compounds against NTM as well as M. tuberculosis, with
either M.  bovis BCG or M.  terrae as surrogates that do not require
P3 biosafety facilities. However, the method may not work if
the chemical or extract to be tested emits ﬂuorescence with a
wavelength close to that of GFP, although the bacteria could be
labeled with alternative molecules that ﬂuoresce at different
wavelengths.
There are several limitations to the results of this study.
Many situations requiring disinfection involve organic mate-
rial, but in our GFP assay only routine growth media is used,
which could lead to an overestimation of the effectiveness of
the QACs tested. We performed the experiments using inoc-
ula from cultures late in the exponential phase (OD600 ∼ 1.0),
and grew the bacteria at 37 ◦C, but it is possible that the results
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ould vary if early log or late stationary phase cultures were
sed, or if the bacteria were grown at a different tempera-
ure. M.  abscessus would likely have grown better at 30 ◦C,
nd therefore the MICs for this bacteria could be higher at
his lower temperature. To test the possibility that the Tween
0 added to the media was affecting the activity of the QAC
ompounds, we  eliminated Tween from the culture media
nd found that the MIC  values were unchanged. Our stud-
es using the GFP method to determine the relative MICs of
ntibiotics against mycobacteria (Fig. 6) were not validated
ith parallel colony counts, however, because of the close cor-
elation of colony counts with ﬂuorescence in our preliminary
tudies (Fig. 1B), we  believe that the relative activity of the
ntibiotics can be trusted, although perhaps not the absolute
IC  values. We  considered that after four days in culture the
ACs might begin to break down  and lose activity, so we  did
ot examine growth after this time point. It is possible that
he QACs selected for few resistant organisms whose growth
ould eventually result in higher ﬂuorescence at later time
oints. However, the four days should have been sufﬁcient
or at least 25 rounds of replication, which would have been
eﬂected by an increase in the ﬂuorescence. We  previously
ublished studies34 showing that exposure to QACs at con-
entrations as high as 9% can induce a non-genetic resistance
tate in M.  abscessus and M.  chelonae, but this resistance is only
o QAC exposures up to 1 h, while in the studies described here
he QACs are present in the media during the entire four days
uring which ﬂuorescence was monitored.
Finally, although the QAC contained in the commercial dis-
nfectant product is much less active than the three other
ACs tested, by itself this may not be a cause for alarm, as
he MICs for all the bacteria tested were still well below the
% concentration of the compound in the commercial presen-
ation, and the lower activity may be advantageous in terms
f less toxicity to humans. However, it is clear from this work
nd previous studies that M. smegmatis is generally much more
ensitive to QACs disinfectants than M. abscessus and M. che-
onae, and therefore the innocuous M. smegmatis should not
e used as a surrogate to assess activity against strains with
reater intrinsic resistance and also greater pathogenic poten-
ial.
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